A scientific statement from the American Heart Association was published in Circulation, with the purpose of providing a thorough review of available evidence on HIV-associated cardiovascular disease.
An asthma exacerbation resulting in hospitalization greatly increases the risk for acute myocardial infarction and ischemic stroke in adults with poorly controlled asthma.
The Endocrine Society published a clinical practice guideline cosponsored by the American Diabetes Association and the European Society of Endocrinology regarding the primary prevention of ASCVD and T2D.
People with HIV and cardiovascular disease have higher levels of the interleukin-1 receptor antagonist and soluble regulator sIL-1R1 up to 10 years before the first myocardial infarction.
Individuals with moderate to very severe COPD and cardiovascular risk factors did not have an increased risk for all-cause mortality or major adverse cardiovascular event occurrence with the use of aclidinium.
The U.S. Food and Drug Administration is launching on April 25, 2019, its “Remove the Risk” campaign, aimed at promoting the safe disposal of unused opioids.
